Sign in

CIK 0001585364

  • Large accelerated filer

PERRIGO Co plc

Sign in to watch
Ticker
PRGO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
Operating
Phone
+1 269-673-8451
Business address
THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
Former names
PERRIGO Co Ltd
  1. 4 Option exercise Director acquired 5,804 shares (option exercise)
  2. 4 Option exercise EVP, Chief Financial Officer acquired 3,964 shares (option exercise)
  3. 4 Open-market buy Director bought 2,500 shares at $41.29 ($103,218)
  4. 4/A Option exercise CEO acquired 30,446 shares (option exercise)
  5. 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 2,662 shares at $41.23 ($109,766)
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise CEO acquired 30,446 shares (option exercise)
  8. 4 Grant or award EVP & President Rx acquired 4,721 shares (grant or award)
  9. 4 Option exercise EVP, Chief Financial Officer acquired 3,629 shares (option exercise)
  10. 4 Option exercise EVP & President CSCA acquired 2,540 shares (option exercise)
  11. 4 Grant or award EVP and CIO acquired 3,758 shares (grant or award)
  12. 4 Option exercise EVP, Chief Scientific Officer acquired 4,322 shares (option exercise)
  13. 4 Option exercise EVP & CHRO acquired 2,780 shares (option exercise)
  14. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 2,269 shares (to pay taxes)
  15. 4 Grant or award EVP, Gbl Ops & SC & CTO acquired 4,121 shares (grant or award)
  16. 4 Grant or award Executive VP, General Counsel acquired 7,571 shares (grant or award)
  17. 4 Grant or award EVP & President CHCI acquired 5,543 shares (grant or award)
  18. 4 Shares withheld for taxes EVP, Chief Scientific Officer gave up 1,396 shares (to pay taxes)
  19. 4 Open-market buy EVP & President CSCA bought 7,513 shares at $43.48 ($326,665)
  20. 3 Insider Initial Statement of Ownership

Page 15 of 41 · 805 filings